These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36198594)

  • 41. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible Autoimmune Encephalitis with Claustrum Sign in case of Acute SARS-CoV-2 Infection.
    Ayatollahi P; Tarazi A; Wennberg R
    Can J Neurol Sci; 2021 May; 48(3):430-432. PubMed ID: 32938510
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
    Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
    J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
    Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
    J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myeloencephalitis as the only presentation of Omicron SARS-CoV-2 infection.
    Dang TQ; La DT; Tran TN
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36379626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19-associated immune-mediated encephalitis mimicking acute-onset Creutzfeldt-Jakob disease.
    Beretta S; Stabile A; Balducci C; DiFrancesco JC; Patruno A; Rona R; Bombino M; Capraro C; Andreetta F; Cavalcante P; Moda F; Citerio G; Foti G; Bogliun G; Ferrarese C
    Ann Clin Transl Neurol; 2021 Dec; 8(12):2314-2318. PubMed ID: 34825771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.
    Brehm TT; Pfefferle S; von Possel R; Karolyi M; Zoufaly A; Wichmann D; Kobbe R; Emmerich P; Nörz D; Aepfelbacher M; Schulze Zur Wiesch J; Addo MM; Schmiedel S; Lütgehetmann M
    J Med Virol; 2022 Oct; 94(10):5038-5043. PubMed ID: 35662058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
    Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
    Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric anti-NMDA receptor encephalitis associated with COVID-19.
    Sarigecili E; Arslan I; Ucar HK; Celik U
    Childs Nerv Syst; 2021 Dec; 37(12):3919-3922. PubMed ID: 33852058
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan.
    Maruki T; Iwamoto N; Kanda K; Okumura N; Yamada G; Ishikane M; Ujiie M; Saito M; Fujimoto T; Kageyama T; Saito T; Saito S; Suzuki T; Ohmagari N
    Clin Infect Dis; 2022 Aug; 75(1):e354-e356. PubMed ID: 34979547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations.
    Almeida LT; Gonçalves AB; Franco-Luiz APM; Silva TBS; Alves PA; Monte-Neto RLD
    Mem Inst Oswaldo Cruz; 2022; 117():e220050. PubMed ID: 35766650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronavirus Disease 2019 Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Shrestha NK; Shrestha P; Burke PC; Nowacki AS; Terpeluk P; Gordon SM
    Clin Infect Dis; 2022 Dec; 75(12):2169-2177. PubMed ID: 35476018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe encephalopathy associated with SARS-CoV-2 Omicron BA.1 variant infection in a neonate.
    Tetsuhara K; Akamine S; Matsubara Y; Fujii S; Kashimada W; Marutani K; Torio M; Morooka Y; Hanaoka N; Fujimoto T; Nakamura-Miwa H; Arai S; Tanaka-Taya K; Furuno K; Mizuno Y; Kira R
    Brain Dev; 2022 Nov; 44(10):743-747. PubMed ID: 35835638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronavirus disease 2019 transmission and symptoms in young children during the severe acute respiratory syndrome coronavirus 2 Delta variant and Omicron variant outbreaks.
    Akaishi T; Ishii T
    J Int Med Res; 2022 May; 50(5):3000605221102079. PubMed ID: 35619217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Shedding and Predictors of Viral Culture Positivity on Vaccinated Healthcare Workers With Mild Coronavirus Disease 2019.
    Luna-Muschi A; Noguera SV; Borges IC; De Paula AV; Côrtes MF; Larocca C; Mari JF; Guimarães LSP; Torres PM; Scaccia N; Villas-Boas LS; da Silva AR; Andrade PS; Teixeira JC; Escadafal C; de Oliveira VF; Tozetto-Mendoza TR; Mendes-Correa MC; Levin AS; Sabino EC; Costa SF
    J Infect Dis; 2022 Nov; 226(10):1726-1730. PubMed ID: 36134610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
    Gu H; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheng SSM; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Cowling BJ; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Feb; 28(2):460-462. PubMed ID: 34860154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review.
    Yiannopoulou K; Vakrakou AG; Anastasiou A; Nikolopoulou G; Sourdi A; Tzartos JS; Kilidireas C; Dimitrakopoulos A
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.